公开(公告)号：US12220398B2

公开(公告)日：2025-02-11

申请号：US15750712

申请日：2016-08-18

Applicant: Eisai R&D Management Co., Ltd.

Inventor： Kiyoshi Okamoto ,  Junji Matsui ,  Corina Dutcus

IPC: A61K31/357 ,  A61K31/47 ,  A61K31/664 ,  A61K31/675 ,  A61P35/00 ,  A61K31/7048

Abstract: A novel tumor therapeutic agent for a combination therapy is disclosed. More specifically, a tumor therapeutic agent used for a combination therapy of lenvatinib, ifosfamide, and etoposide is disclosed.

公开(公告)号：US20190000797A1

公开(公告)日：2019-01-03

申请号：US15750712

申请日：2016-08-18

Applicant: Eisai R&D Management Co., Ltd.

Inventor： Kiyoshi Okamoto ,  Junji Matsui ,  Corina Dutcus

IPC: A61K31/357 ,  A61K31/47 ,  A61P35/00 ,  A61K31/664

Abstract: A novel tumor therapeutic agent for a combination therapy is disclosed. More specifically, a tumor therapeutic agent used for a combination therapy of lenvatinib, ifosfamide, and etoposide is disclosed.